Sign In
Buy OCX
$3.20
+0 (+0%)
At Close: Sep 16, 2025
OncoCyte Corporation (OCX) Q1 2024 Earnings Call Transcript
10:15pm, Wednesday, 15'th May 2024
OncoCyte Corporation (NASDAQ:OCX ) Q1 2024 Earnings Conference Call May 15, 2024 4:30 PM ET Company Participants Jeff Ramson - Investor Relations Josh Riggs - President and Chief Executive Officer Con
ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
04:06pm, Wednesday, 15'th May 2024
Conference Call on Wednesday, May 15, 2024, at 1:30 p.m. PT / 4:30 p.m.
Oncocyte Reports First Quarter 2024 Financial Results
04:05pm, Wednesday, 15'th May 2024
IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024.
Oncocyte to Announce First Quarter 2024 Financial Results
08:00am, Monday, 13'th May 2024
Conference Call and Webcast on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m.
Buffett Grabs More of This Stock, Plus Other Notable Insider Buying
08:45am, Sunday, 21'st Apr 2024
At the end of the previous week, the Oracle of Omaha yet again boosted his stake in a media giant's tracking stocks, even with shares still in retreat.
The Eclipse Foundation Unveils Open Community Experience
06:12am, Thursday, 18'th Apr 2024
BRUSSELS, Belgium, April 18, 2024 (GLOBE NEWSWIRE) — The Eclipse Foundation, one of the world’s largest open source foundations, is proud to announce the launch of Open Community Experience (OCX),
OncoCyte Corporation (OCX) Q4 2023 Earnings Call Transcript
01:44pm, Friday, 12'th Apr 2024
OncoCyte Corporation (NASDAQ:OCX ) Q4 2023 Results Conference Call April 12, 2024 8:00 AM ET Company Participants Jeff Ramson - PCG Advisory Josh Riggs - President, CEO Conference Call Participants Mi
ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS
06:00am, Friday, 12'th Apr 2024
Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m.
Oncocyte Reports Full Year 2023 Financial Results
06:00am, Friday, 12'th Apr 2024
IRVINE, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the year ended December 31, 2023.
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
09:48pm, Thursday, 11'th Apr 2024
IRVINE, CA, April 11, 2024 – Oncocyte Corporation (NASDAQ: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company, today announced that it has entered into definitive securitie
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
09:46pm, Thursday, 11'th Apr 2024
IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a precision diagnostics company, today announced that it has entered into d
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
05:30pm, Thursday, 11'th Apr 2024
- Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-Rad granted subsequent investment option upo
ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
04:05pm, Tuesday, 09'th Apr 2024
Conference Call and Webcast on Friday, April 12, 2024, at 5:00 a.m. PT / 8:00 a.m.
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
04:05pm, Tuesday, 09'th Apr 2024
IRVINE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that the company will release its fourth quarter and full year
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
08:02am, Tuesday, 16'th Jan 2024
IRVINE, CA, January 16, 2024 – Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today announced that CEO Josh Riggs will be presenting a corporate overview at the upcoming Sequir
